Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR1 | P11362 | 3/20 | 0.35 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.35 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.33 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.33 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | MTOR | P42345 | 1/20 | 0.33 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.33 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.33 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.33 |
| ▸ | NT5E | P21589 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20669062 | 1.00 | FGFR1 (0.35) | FGFR1SLC22A6PDE4DPDE3ASLC29A1 | |
| SCHEMBL22765438 | 1.00 | FGFR1 (0.35) | FGFR1SLC22A6PDE4DPDE3ASLC29A1 | |
| SCHEMBL19245259 | 0.89 | FGFR1 (0.34) | FGFR1SLC22A6PDE4DPDE3ASLC29A1 | |
| SCHEMBL18324638 | 0.88 | FGFR1 (0.36) | FGFR1SLC22A6PDE4DPDE3ASLC29A1 | |
| SCHEMBL19049978 | 0.81 | FGFR1 (0.39) | FGFR1SLC22A6PDE4DPDE3ASLC29A1 | |
| SCHEMBL23950133 | 0.80 | FGFR1 (0.37) | FGFR1SLC22A6PDE4DPDE3ASLC29A1 | |
| SCHEMBL22847460 | 0.80 | FGFR1 (0.37) | FGFR1SLC22A6PDE4DPDE3ASLC29A1 | |
| SCHEMBL22351846 | 0.80 | — | — | |
| SCHEMBL19050051 | 0.79 | FGFR1 (0.38) | FGFR1SLC22A6PDE4DPDE3ASLC29A1 | |
| SCHEMBL16426709 | 0.78 | FGFR1 (0.43) | FGFR1SLC22A6PDE4DPDE3ASLC29A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2405908-B1 | PHARMACEUTICAL COMBINATION OF RDEA119/BAY 869766 AND GEMCITABINE FOR THE TREATMENT OF SPECIFIC CANCERS | ARDEA BIOSCIENCES INC (US) | 2016-12-21 | — | — | EP | disclosed |